ZA200404444B - A process for the preparation of a non-toxic anthrax vaccine - Google Patents

A process for the preparation of a non-toxic anthrax vaccine

Info

Publication number
ZA200404444B
ZA200404444B ZA200404444A ZA200404444A ZA200404444B ZA 200404444 B ZA200404444 B ZA 200404444B ZA 200404444 A ZA200404444 A ZA 200404444A ZA 200404444 A ZA200404444 A ZA 200404444A ZA 200404444 B ZA200404444 B ZA 200404444B
Authority
ZA
South Africa
Prior art keywords
preparation
anthrax vaccine
toxic
toxic anthrax
vaccine
Prior art date
Application number
ZA200404444A
Other languages
English (en)
Inventor
Bhatnagar Rakesh
Batra Smriti
Chuahan Vibha
Singh Aparna
Ahuja Nidhi
Kumar Praveen
Gupta Pankaj
Original Assignee
Bhatnagar Rakesh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bhatnagar Rakesh filed Critical Bhatnagar Rakesh
Publication of ZA200404444B publication Critical patent/ZA200404444B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200404444A 2001-12-05 2004-06-04 A process for the preparation of a non-toxic anthrax vaccine ZA200404444B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1222DE2001 2001-12-05

Publications (1)

Publication Number Publication Date
ZA200404444B true ZA200404444B (en) 2006-03-29

Family

ID=11097141

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200404444A ZA200404444B (en) 2001-12-05 2004-06-04 A process for the preparation of a non-toxic anthrax vaccine

Country Status (12)

Country Link
US (1) US7888490B2 (ru)
EP (2) EP1958960A3 (ru)
JP (1) JP2005511059A (ru)
CN (1) CN1694722A (ru)
AU (1) AU2002242935A1 (ru)
BR (1) BRPI0215039A2 (ru)
CA (1) CA2469671A1 (ru)
IL (1) IL162381A0 (ru)
MX (1) MXPA04005538A (ru)
RU (1) RU2287581C2 (ru)
WO (1) WO2003048390A1 (ru)
ZA (1) ZA200404444B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481043B2 (en) * 2001-06-22 2013-07-09 Cpex Pharmaceuticals, Inc. Nasal immunization
WO2005081749A2 (en) * 2004-01-23 2005-09-09 Avanir Pharmaceuticals, Inc. Neutralizing human antibodies to anthraxtoxin
US20060246079A1 (en) * 2003-11-14 2006-11-02 Morrow Phillip R Neutralizing human antibodies to anthrax toxin
US8409590B2 (en) 2004-02-11 2013-04-02 Ligocyte Pharmaceuticals, Inc. Anthrax antigens and methods of use
US7947268B2 (en) * 2005-11-14 2011-05-24 University Of Maryland, Baltimore Salmonella based oral vaccines for anthrax
CN100362094C (zh) * 2006-02-14 2008-01-16 中国人民解放军军事医学科学院生物工程研究所 一株无pX01和pX02质粒的炭疽杆菌菌株及其用途
GB0607462D0 (en) * 2006-04-13 2006-05-24 Avecia Ltd Assay
AU2007259329A1 (en) * 2006-05-12 2007-12-21 Farris, Darise Anthrax compositions and methods of use and production
WO2008152655A1 (en) * 2007-06-11 2008-12-18 Panacea Biotec Limited Limited Anthrax fusion proteins, compositions and uses thereof
WO2008152654A1 (en) * 2007-06-11 2008-12-18 Panacea Biotec Limited Anthrax fusion proteins, compositions and uses thereof
JP5701760B2 (ja) 2008-10-02 2015-04-15 ファーマシーネ，インコーポレイテッド 炭疽菌ワクチン製剤とその用途
CN101798565B (zh) * 2010-02-26 2013-08-07 中国人民解放军军事医学科学院生物工程研究所 能在芽孢表面展示pa20蛋白的炭疽芽孢杆菌及其应用
WO2012171329A1 (zh) * 2011-06-15 2012-12-20 Du Quan 一种核酸分离的方法及其应用
CN102516394B (zh) * 2011-12-14 2014-07-09 中国人民解放军军事医学科学院生物工程研究所 CMG2突变体和Fc的融合蛋白及其编码基因与应用
CN105797148B (zh) * 2016-03-30 2020-01-14 中国疾病预防控制中心传染病预防控制所 一种无毒炭疽活疫苗及无毒炭疽菌株
CN105749265B (zh) * 2016-03-30 2020-03-27 中国疾病预防控制中心传染病预防控制所 一种二价炭疽疫苗
NL2027383B1 (en) 2020-01-24 2022-04-06 Aim Immunotech Inc Methods, compositions, and vaccines for treating a virus infection

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2017606A (en) 1932-12-24 1935-10-15 Sharp & Dohme Inc Anthrax antigen preparation and product
US2151364A (en) 1937-06-02 1939-03-21 Cutter Lab Anthrax vaccine
RU2115433C1 (ru) 1992-08-28 1998-07-20 Научно-исследовательский институт микробиологии МО РФ Вакцина сибиреязвенная комбинированная
DE69940157D1 (en) 1998-07-10 2009-02-05 U S Medical Res Inst Of Infect Anthrax-impfstoff
FR2798291B1 (fr) * 1999-09-10 2005-01-14 Pasteur Institut Compositions acellulaires immunogenes et compositions acellulaires vaccinales contre bacillus anthracis
WO2001045639A2 (en) * 1999-12-22 2001-06-28 The Ohio State University Research Foundation Methods for protecting against lethal infection with bacillus anthracis
MXPA02010826A (es) 2000-05-04 2006-03-09 Harvard College Compuestos y metodos para el tratamiento y la prevencion de infeccion bacteriana.
US20040166120A1 (en) * 2001-06-08 2004-08-26 Thomas Lawrence J. Vaccination against anthrax
GB0116798D0 (en) * 2001-07-10 2001-08-29 Secr Defence Expression system
GB0126266D0 (en) * 2001-11-01 2002-01-02 Microbiological Res Authority Anthrax antigenic compositions

Also Published As

Publication number Publication date
RU2004120293A (ru) 2005-04-20
RU2287581C2 (ru) 2006-11-20
US7888490B2 (en) 2011-02-15
BRPI0215039A2 (pt) 2016-06-28
AU2002242935A8 (en) 2003-06-17
WO2003048390A1 (en) 2003-06-12
US20050063986A1 (en) 2005-03-24
EP1453534A1 (en) 2004-09-08
JP2005511059A (ja) 2005-04-28
CN1694722A (zh) 2005-11-09
IL162381A0 (en) 2005-11-20
MXPA04005538A (es) 2005-06-08
EP1958960A2 (en) 2008-08-20
WO2003048390A8 (en) 2004-02-05
CA2469671A1 (en) 2003-06-12
EP1958960A3 (en) 2009-01-07
AU2002242935A1 (en) 2003-06-17

Similar Documents

Publication Publication Date Title
HK1067891A1 (en) Influenza vaccine composition
HK1168792A1 (en) Aripiprazole oral solution
AU2002353378A8 (en) Vaccine for periodontal disease
ZA200404444B (en) A process for the preparation of a non-toxic anthrax vaccine
HUP0402471A3 (en) Vaccine
GB0407935D0 (en) Vaccine
HUP0402027A3 (en) Process for the preparation of a xantophyll
HUP0303372A3 (en) Vaccine
EP1423141A4 (en) VACCINE
GB0306611D0 (en) Novel vaccine
GB0121171D0 (en) Vaccine
AU2002322059A1 (en) Improved vaccination against anthrax
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
HRP20040161A2 (en) Process for the preparation of a 14-hydroxynormorphinone derivative
HUP0201837A3 (en) Process for preparation n-carboxy-anhydrides
EP1429615A4 (en) ORAL VACCINES
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
HU0204443D0 (en) Process for preparing fluoroformates
GB0123828D0 (en) Vaccine production
GB0129338D0 (en) Vaccination
GB0113667D0 (en) Process for the preparation of endo-5-norbornene-2-ol
HK1071358A1 (en) Process for the preparation of 5-formylphthalide
HRP20010190B1 (en) Process for the preparation of alpha-arbutine
SI1385850T1 (en) New process for the preparation of oxabispidines